BARD1 26-327 pET28a Citations (3)

Originally described in: A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.
Brzovic PS, Lissounov A, Christensen DE, Hoyt DW, Klevit RE Mol Cell. 2006 Mar 17. 21(6):873-80. PubMed Journal

---

Articles Citing BARD1 26-327 pET28a

Articles
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs. Atipairin A, Canyuk B, Ratanaphan A. Breast Cancer Res Treat. 2011 Feb;126(1):203-9. doi: 10.1007/s10549-010-1182-7. Epub 2010 Sep 29. PubMed
Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature. Atipairin A, Canyuk B, Ratanaphan A. J Biol Inorg Chem. 2011 Feb;16(2):217-26. doi: 10.1007/s00775-010-0718-y. Epub 2010 Oct 22. PubMed
In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein. Atipairin A, Ratanaphan A. Breast Cancer (Auckl). 2011;5:201-8. doi: 10.4137/BCBCR.S8184. Epub 2011 Sep 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.